Literature DB >> 18769336

Do prostatic transition zone tumors have a distinct morphology?

Joaquin J Garcia1, Hikmat A Al-Ahmadie, Anuradha Gopalan, Satish K Tickoo, Peter T Scardino, Victor E Reuter, Samson W Fine.   

Abstract

Previous studies have proposed that the morphologic spectrum of prostatic glands of variable size with tall columnar cells displaying basally oriented nuclei and clear to pale pink cytoplasm (TZ-LOOK) is characteristic of the well to moderately differentiated component of transition zone (TZ) tumors. However, the specificity of these findings has not been well studied. In a recent report, we identified dominant peripheral zone (PZ) and TZ tumors situated anterior to the prostatic urethra. Currently, we evaluate the histopathologic features of 215 dominant tumors, including 63 TZ and 73 anterior PZ lesions and an additional cohort of 79 posterior PZ tumors, in radical prostatectomy specimens, to identify the prevalence of this morphology in tumors of different zonal origin. Each dominant tumor was assigned a TZ-LOOK extent score of 0 to 4, with 0 = no such morphology, 1 = 1% to 25%, 2 = 26% to 50%, 3 = 51% to 75%, and 4 = >75%. Overall, 121/215 (56%) tumors showed some degree of this histology, including 56 of 63 (89%) TZ tumors and 65 of 152 (43%) PZ tumors (P<0.0001). Thirty-seven of 215 (17%) lesions had scores of 3 to 4, with 31 (84%) of these being of TZ origin. However, only 31/63 (49%) TZ tumors had >50% TZ-LOOK. Among PZ tumors, 6/152 (4%) had predominant (>50%) TZ-LOOK morphology, yet 23/152 (15%) of all PZ tumors and 23/65 (35%) of PZ tumors displaying any degree of TZ-LOOK had scores of 2 to 3 (>25%; nonfocal). In tumors of both zones with predominant (scores 3 to 4; >50%) TZ-LOOK histology, darker glands of usual acinar adenocarcinoma was often seen at the periphery. Conversely, in tumors with nonpredominant TZ-LOOK (scores 1 to 2; <or=50%), these glands were frequently admixed with small glands bearing dark cytoplasm. In this series, we demonstrate that some degree of TZ-LOOK morphology is twice as frequent in dominant TZ tumors than in PZ tumors. Tumors demonstrating >50% of this histology are very likely of TZ origin, but this scenario occurs in only half of TZ tumors. Importantly, the TZ-LOOK is nonfocal in up to 35% of PZ tumors exhibiting any degree of this morphology. Given this lack of specificity, caution should be exercised in assigning zone of origin based on this histologic appearance, especially in limited samples such as prostate needle biopsy.

Entities:  

Mesh:

Year:  2008        PMID: 18769336      PMCID: PMC3010973          DOI: 10.1097/PAS.0b013e318172ee97

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  46 in total

1.  Evaluation of transition zone and lateral sextant biopsies for prostate cancer detection after initial sextant biopsy.

Authors:  Klaus G Fink; Georg Hutarew; Brigitte Esterbauer; Akos Pytel; Andreas Jungwirth; Otto Dietze; Nikolaus T Schmeller
Journal:  Urology       Date:  2003-04       Impact factor: 2.649

2.  Value of systematic transition zone biopsy in the detection of prostate cancer.

Authors:  H Maeda; S Ishitoya; Y Aoki; K Okubo; T Okada; S Maekawa; Y Arai
Journal:  Int J Urol       Date:  1997-11       Impact factor: 3.369

3.  Indications for transition zone biopsy in the detection of prostatic carcinoma.

Authors:  N E Fleshner; W R Fair
Journal:  J Urol       Date:  1997-02       Impact factor: 7.450

4.  Routine transition zone and seminal vesicle biopsies in all patients undergoing transrectal ultrasound guided prostate biopsies are not indicated.

Authors:  M K Terris; T Q Pham; M M Issa; J N Kabalin
Journal:  J Urol       Date:  1997-01       Impact factor: 7.450

5.  Limitations of transition zone needle biopsy findings in the prediction of transition zone cancer and tissue composition of benign nodular hyperplasia.

Authors:  J McNeal; J Noldus
Journal:  Urology       Date:  1996-11       Impact factor: 2.649

6.  Use of repeat sextant and transition zone biopsies for assessing extent of prostate cancer.

Authors:  J I Epstein; P C Walsh; J Sauvageot; H B Carter
Journal:  J Urol       Date:  1997-11       Impact factor: 7.450

7.  Value of systematic transition zone biopsies in the early detection of prostate cancer.

Authors:  M Bazinet; P I Karakiewicz; A G Aprikian; C Trudel; S Aronson; M Nachabé; F Péloquin; J Dessureault; M Goyal; W Zheng; L R Bégin; M M Elhilali
Journal:  J Urol       Date:  1996-02       Impact factor: 7.450

Review 8.  Zonal origin of prostatic adenocarcinoma: are there biologic differences between transition zone and peripheral zone adenocarcinomas of the prostate gland?

Authors:  D J Grignon; W A Sakr
Journal:  J Cell Biochem Suppl       Date:  1994

9.  Adenosis of the prostate. Histologic features in needle biopsy specimens.

Authors:  P B Gaudin; J I Epstein
Journal:  Am J Surg Pathol       Date:  1995-07       Impact factor: 6.394

10.  Prostatic transition zone biopsies in men with previous negative biopsies and persistently elevated serum prostate specific antigen values.

Authors:  D W Keetch; W J Catalona
Journal:  J Urol       Date:  1995-11       Impact factor: 7.450

View more
  7 in total

1.  Positive surgical margins at radical prostatectomy predict prostate cancer specific mortality.

Authors:  Jonathan L Wright; Bruce L Dalkin; Lawrence D True; William J Ellis; Janet L Stanford; Paul H Lange; Daniel W Lin
Journal:  J Urol       Date:  2010-06       Impact factor: 7.450

2.  Impact of surgical margin status on prostate-cancer-specific mortality.

Authors:  Heather J Chalfin; Michael Dinizo; Bruce J Trock; Zhaoyong Feng; Alan W Partin; Patrick C Walsh; Elizabeth Humphreys; Misop Han
Journal:  BJU Int       Date:  2012-07-12       Impact factor: 5.588

Review 3.  Prostate zones and cancer: lost in transition?

Authors:  Amin Ali; Alexander Du Feu; Pedro Oliveira; Ananya Choudhury; Robert G Bristow; Esther Baena
Journal:  Nat Rev Urol       Date:  2021-10-19       Impact factor: 14.432

4.  3T multiparametric MR imaging, PIRADSv2-based detection of index prostate cancer lesions in the transition zone and the peripheral zone using whole mount histopathology as reference standard.

Authors:  Nazanin Hajarol Asvadi; Sohrab Afshari Mirak; Amirhossein Mohammadian Bajgiran; Pooria Khoshnoodi; Pornphan Wibulpolprasert; Daniel Margolis; Anthony Sisk; Robert E Reiter; Steven S Raman
Journal:  Abdom Radiol (NY)       Date:  2018-11

5.  TMPRSS2-ERG rearrangement in dominant anterior prostatic tumours: incidence and correlation with ERG immunohistochemistry.

Authors:  Anuradha Gopalan; Margaret A Leversha; Maria E Dudas; Alexandra C Maschino; Jeremy Chang; Hikmat A Al-Ahmadie; Ying-Bei Chen; Satish K Tickoo; Victor E Reuter; Samson W Fine
Journal:  Histopathology       Date:  2013-05-23       Impact factor: 5.087

Review 6.  The Role of Proteomics in Biomarker Development for Improved Patient Diagnosis and Clinical Decision Making in Prostate Cancer.

Authors:  Claire L Tonry; Emma Leacy; Cinzia Raso; Stephen P Finn; John Armstrong; Stephen R Pennington
Journal:  Diagnostics (Basel)       Date:  2016-07-18

7.  Comparison of Immunohistochemistry Expression of CK7, HMWK and PSA in High-Grade Prostatic Adenocarcinoma and Bladder Transitional Cell Carcinoma.

Authors:  Reza Gheitasi; Esmaeil Sadeghi; Mohammad Jafari
Journal:  Iran J Pathol       Date:  2020-11-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.